Short Interest in Health Catalyst, Inc. (NASDAQ:HCAT) Rises By 15.8%

Health Catalyst, Inc. (NASDAQ:HCAT) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 1,760,000 shares, a growth of 15.8% from the March 31st total of 1,520,000 shares. Based on an average daily trading volume, of 616,300 shares, the days-to-cover ratio is presently 2.9 days.

Health Catalyst Price Performance

HCAT stock opened at $6.22 on Wednesday. The stock has a 50-day moving average price of $7.25 and a two-hundred day moving average price of $8.22. Health Catalyst has a 12-month low of $5.45 and a 12-month high of $14.37. The company has a current ratio of 4.42, a quick ratio of 4.42 and a debt-to-equity ratio of 0.62. The company has a market cap of $364.24 million, a PE ratio of -2.96 and a beta of 1.29.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Thursday, February 22nd. The company reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.06. The company had revenue of $75.08 million for the quarter, compared to analysts’ expectations of $73.67 million. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. As a group, research analysts predict that Health Catalyst will post -0.47 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Los Angeles Capital Management LLC acquired a new position in shares of Health Catalyst in the fourth quarter worth about $108,000. Tower Research Capital LLC TRC increased its holdings in Health Catalyst by 285.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 12,018 shares of the company’s stock valued at $111,000 after buying an additional 8,900 shares during the last quarter. Stratos Wealth Partners LTD. bought a new stake in Health Catalyst in the third quarter valued at about $114,000. MQS Management LLC bought a new stake in Health Catalyst in the third quarter valued at about $116,000. Finally, Versor Investments LP bought a new stake in Health Catalyst in the third quarter valued at about $117,000. Institutional investors and hedge funds own 85.00% of the company’s stock.

Analyst Ratings Changes

HCAT has been the subject of several research reports. Barclays initiated coverage on Health Catalyst in a report on Wednesday, January 3rd. They set an “overweight” rating and a $14.00 price objective for the company. Evercore ISI reduced their price objective on Health Catalyst from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $16.00 price objective on shares of Health Catalyst in a report on Wednesday, April 10th. Canaccord Genuity Group reduced their price objective on Health Catalyst from $12.00 to $11.00 and set a “buy” rating for the company in a report on Friday, February 23rd. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $15.00 price objective (down from $17.00) on shares of Health Catalyst in a report on Friday, February 23rd. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Health Catalyst currently has an average rating of “Moderate Buy” and a consensus target price of $12.10.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.